Since the patients in the T2D group had a mild condition (HbA1c<7%), the decrease of the surface expression of FcεRI, CD45, CD117, and CD203c may be sharper in patients with severe T2D. The gene discussed is ENPP3; the disease is type 2 diabetes mellitus.